[HTML][HTML] The contribution of complement to the pathogenesis of IgA nephropathy: are complement-targeted therapies moving from rare disorders to more common …
F Poppelaars, B Faria, W Schwaeble… - Journal of clinical …, 2021 - mdpi.com
Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney
failure for which there is no disease-specific treatment. However, this could change, since …
failure for which there is no disease-specific treatment. However, this could change, since …
[PDF][PDF] The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble… - J. Clin. Med, 2021 - pdfs.semanticscholar.org
Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney
failure for which there is no disease-specific treatment. However, this could change, since …
failure for which there is no disease-specific treatment. However, this could change, since …
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble… - Journal of Clinical …, 2021 - search.proquest.com
Abstract Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and
kidney failure for which there is no disease-specific treatment. However, this could change …
kidney failure for which there is no disease-specific treatment. However, this could change …
[PDF][PDF] The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble, MR Daha - J. Clin. Med, 2021 - core.ac.uk
Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney
failure for which there is no disease-specific treatment. However, this could change, since …
failure for which there is no disease-specific treatment. However, this could change, since …
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble… - Journal of Clinical …, 2021 - cir.nii.ac.jp
抄録< jats: p> Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease
and kidney failure for which there is no disease-specific treatment. However, this could …
and kidney failure for which there is no disease-specific treatment. However, this could …
[PDF][PDF] The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble, MR Daha - New Insights into the … - mdpi.com
Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney
failure for which there is no disease-specific treatment. However, this could change, since …
failure for which there is no disease-specific treatment. However, this could change, since …
The contribution of complement to the pathogenesis of IgA nephropathy: Are complement-targeted therapies moving from rare disorders to more common diseases?
F Poppelaars, B Faria… - Journal of Clinical …, 2021 - repositorio-aberto.up.pt
Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney
failure for which there is no disease-specific treatment. However, this could change, since …
failure for which there is no disease-specific treatment. However, this could change, since …
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble, MR Daha - 2021 - repository.cam.ac.uk
Abstract Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and
kidney failure for which there is no disease-specific treatment. However, this could change …
kidney failure for which there is no disease-specific treatment. However, this could change …
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria, W Schwaeble… - Journal of Clinical …, 2021 - europepmc.org
Abstract Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and
kidney failure for which there is no disease-specific treatment. However, this could change …
kidney failure for which there is no disease-specific treatment. However, this could change …
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common …
F Poppelaars, B Faria… - Journal of …, 2021 - scholarlypublications …
Primary IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and kidney
failure for which there is no disease-specific treatment. However, this could change, since …
failure for which there is no disease-specific treatment. However, this could change, since …